← Evidence map

ArticleBrain : a journal of neurology2016

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.

Lydie Boussicault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

110 papers cite itlatest 60 shown

2016
…
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26912634